Rethinking Pharmaceutical Good Distribution Practice

Synopsis

Recent research shows there is an overwhelming recognition of the need for a more holistic, joined-up approach to pharmaceutical Good Distribution Practice and a pressing need for regulatory compliance to reflect rapidly changing market realities. To fill these gaps a group of leading pharma supply-chain stakeholders has come together to create an independent Good Distribution Practice (GDP) program to champion the improvement of global GDP practices and quality management systems.

The GDP-Universal Compliance Initiative (GDP-UCI) is a cross industry collaborative model that will build on current best practices by applying evidence-based improvements to the control of medicine distribution and the regulatory compliance thereof.  For this to happen the industry needs to come together.